Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GC-Rise Pharmaceutical To Launch Remifemin In China

This article was originally published in PharmAsia News

Executive Summary

GC-Rise Pharmaceutical, a firm focusing on women's health, will launch Remifemin in the country soon. The drug, made from the extract of the medicinal plant black cohosh for treating menopausal symptoms, is produced by German company Schaper & Brümmer. Remifemin has been used worldwide for more than 50 years; its effectiveness and reliability have also been proven by strict trials in several Chinese authoritative clinical centers. Patients who are not candidates for hormone replacement therapy or who have concerns about the therapy's safety will have more choice after Remifemin enters the market. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts